H.S.G
HuntingtonStudyGroup

 ARTICLES

Huntington Study Group (Kieburtz K, primary author). The Unified Huntington's Disease Rating Scale: Reliability and Consistency. Mov Disord 1996; 11:136-142.

Huntington Study Group (Marshall F, primary author). Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. Neurology 1998; 50:1366-1373.

Parkinson Study Group, Huntington Study Group and Movement Disorder Society. Twelfth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Etiology, Pathogenesis and Treatment of Huntington's Disease. Mov Disord 1998; 13:858-863.

ABSTRACTS

Huntington Study Group (Como P, primary author). Internal validity and consistency of the Unified Huntington's Disease Rating Scale (UHDRS) (abstract), Neurology 45(Suppl 4) April 1995, p. A254.

Huntington Study Group (Marshall FJ, primary author). Inter-laboratory variability of (CAG)n determinations in Huntington's disease (HD). Neurology 1996; 46:A258.

Huntington Study Group (Paulsen JS, primary author). The clinical utility of the Stroop Test A in a multicenter study of Huntington's disease. J Intl Neuropsychol Society 1996; 2:35.

Huntington Study Group (Bylsma FW, primary author). Noncognitive symptoms in Huntington's disease. J Intl Neuropsychol Society 1996; 2:35.

Huntington Study Group (Como P, primary author). Neuropsychological assessment in multicenter clinical trials. J Intl Neuropsychol Society 1996; 2:44.

Huntington Study Group (Marshall FJ, primary author). Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. Mov Disord 1996; 11:59.

Marshall FJ, Taylor S and the Huntington Study Group. Aggression and irritability in Huntington disease: a survey of treatment patterns. Neurology 1996; 48:A49. 

REPORTS, RELEASES AND POSITION PAPERS

1. Huntington Study Group To Plan and Carry Out Clinical Trials (November 15, 1993).

2. Huntington Study Group Ethical and Conflict-of-Interest Guidelines (June, 1994).

3. The Huntington Study Group Moves Forward to Plan and Conduct Clinical Research Trials (August, 1994).

4. HSG Progress Report, 1993-94 (December, 1994).

5. HSG Policy on Non-Disclosure of CAG Trinucleotide Repeat Length (CAGn) Genetic (DNA) Information (February 10, 1995).

6. HSG Accomplishments and Goals, 1995-1996 (March, 1996)

7. Constitution and Bylaws of the HSG (September 13, 1996).

8. HSG Position Statement On Experimental Surgical Treatments In HD (January 10, 1997) K. Kieburtz, K. Shannon for the Surgical Approaches Working Group and the HSG Executive Committee.

REPORTS SUPPORTED BY THE HUNTINGTON STUDY GROUP

1. Ordway JM, Tallaksen-Greene S, Gutekunst CA, Bernstein EM, Cearley JA, Wiener HW, Dure LS, Lindsey R, Hersch SM, Jope RS, Albin RL, Detloff PJ. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997; 91:753-763.